DOSKOCIL MANUFACTURING CO INC
NT 10-Q, 1999-11-15
PLASTICS PRODUCTS, NEC
Previous: CELLPOINT INC, NT 10-Q, 1999-11-15
Next: SUNBURST ACQUISITIONS IV INC, NT 10-Q, 1999-11-15



<PAGE>   1
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING



(Check One):      [ ] Form 10-K          [ ] Form 11-K            [ ] Form 20-F
                  [X] Form 10-Q          [ ] Form N-SAR

                                                                 ---------------
                                                                 SEC FILE NUMBER
                                                                 333-37081
                                                                 ---------------
For Period Ended:  September 30, 1999
                   ---------------------------------------------
                                                                 ---------------
                                                                 CUSIP NUMBER
                                                                 ---------------
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR

For the Transition Period Ended:
                                 -------------------------------

================================================================================

  Read Instruction (on last page) Before Preparing Form. Please Print or Type.

NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS
VERIFIED ANY INFORMATION CONTAINED HEREIN.

================================================================================


If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:

- --------------------------------------------------------------------------------
PART I.  REGISTRANT INFORMATION
- --------------------------------------------------------------------------------

Full Name of Registrant:    Doskocil Manufacturing Company, Inc.
                        --------------------------------------------------------

Former Name if Applicable:  N/A
                          ------------------------------------------------------

Address of Principal Executive Office(Street and Number): 4209 Barnett Boulevard
                                                         -----------------------

- --------------------------------------------------------------------------------

City, State and Zip Code:  Arlington, Texas 76017
                           -----------------------------------------------------

- --------------------------------------------------------------------------------
PART II.  RULES 12b-25 (b) AND (c)
- --------------------------------------------------------------------------------

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate.)

[X] (a) The reasons described in reasonable detail in Part III of this form
        could not be eliminated without unreasonable effort or expense;


<PAGE>   2

[X] (b) The subject annual report, semi-annual report, transition report on
        Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof will be filed
        on or before the fifteenth calendar day following the prescribed due
        date; or the subject quarterly report or transition report on Form 10-Q,
        or portion thereof will be filed on or before the fifth calendar day
        following the prescribed due date; and

[ ] (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
        has been attached if applicable.

- --------------------------------------------------------------------------------
PART III.  NARRATIVE
- --------------------------------------------------------------------------------

State below in reasonable detail the reasons why Form 10-K, 11-K, 20-F, 10-Q,
N-SAR, or the transition report or portion thereof could not be filed within the
prescribed time period. (Attach Extra Sheets if Needed.)

The Company has not been able to complete its Report on Form 10-Q. In July 1999
the Company commenced implementation of the Oracle financial, manufacturing and
distribution modules. As a result, the Company has experienced some delays in
the preparation of financial information. The Company currently anticipates the
filing of its annual report on Form 10-Q to occur no later than 5 calendar days
following the prescribed due date in accordance with Rule 12b-25.


                                       2

<PAGE>   3
- --------------------------------------------------------------------------------
PART IV.  OTHER INFORMATION
- --------------------------------------------------------------------------------

(1)  Name and telephone number of person to contact in regard to this
     notification

       John Casey                                    (817) 467-5116 x1169
- --------------------------------------------------------------------------------
         (Name)                                 (Area Code) (Telephone Number)

(2)  Have all other periodic reports required under
     section 13 or 15(d) of the Securities Exchange
     Act of 1934 or section 30 of the Investment
     Company Act of 1940 during the preceding 12
     months or for such shorter period that the
     registrant was required to file such report(s)
     been filed? If the answer is no, identify report(s).      [X] Yes   [ ] No

(3)  Is it anticipated that any significant change in
     results of operations from the corresponding period
     for the last fiscal year will be reflected by the
     earnings statements to be included in the subject
     report or portion thereof?                                [X] Yes   [ ] No

If so: attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.

SEE ATTACHED "EXHIBIT A."

================================================================================

                      Doskocil Manufacturing Company, Inc.
                  --------------------------------------------
                  (Name of Registrant as specified in charter)

has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.

Date:   November 15, 1999               By:  /s/ JOHN CASEY
     -----------------------------         -------------------------------------
                                        Name:    John Casey
                                        Title:   Chief Financial Officer

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.

        ----------------------------------------------------------------
                                   ATTENTION
       INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL
                    CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001)
        ----------------------------------------------------------------

                              GENERAL INSTRUCTIONS

1.   This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General
     Rules and Regulations under the Securities Exchange Act of 1934.

2.   One signed original and four conformed copies of this form and amendments
     thereto must be completed and filed with the Securities and Exchange
     Commission, Washington, D.C. 20549, in accordance with Rule 0-3 of the
     General Rules and Regulations under the Act. The information contained in
     or filed with the form will be made a matter of public record in the
     Commission files.

3.   A manually signed copy of the form and amendments thereto shall be filed
     with each national securities exchange on which any class of securities of
     the registrant is registered.

4.   Amendments to the notifications must also be filed on form 12b-25 but need
     not restate information that has been correctly furnished. The form shall
     be clearly identified as an amended notification.

5.   Electronic Filers. This form shall not be used by electronic filers unable
     to timely file a report solely due to electronic difficulties. Filers
     unable to submit a report within the time period prescribed due to
     difficulties in electronic filing should comply with either Rule 201 or
     Rule 202 of Regulation S-T ((S)232.201 or (S)232.202 of this chapter) or
     apply for an adjustment in filing date pursuant to Rule 13(b) of Regulation
     S-T ((S)232.13(b) of this chapter.

                                       3

<PAGE>   4
EXHIBIT A



Doskocil Manufacturing Company, Inc.
Statements of Operations

<TABLE>
<CAPTION>

                                                               Twelve Months Ended
                                                                ($ in thousands)
                                                        ------------------------------
                                                            Sep 30,           Sep 30,
                                                             1999              1998
                                                        -------------    -------------
<S>                                                     <C>              <C>
Net sales                                               $      36,134    $      39,975
Cost of goods sold                                             25,228           22,604
                                                        -------------    -------------

Gross profit                                                   10,906           17,371
Selling, general and administrative expense                    12,642           11,108
                                                        -------------    -------------

Operating income                                               (1,736)           6,263

Other (income) expense:
       Interest expense and other financing costs               4,677            4,122

       Other, net                                                (433)               4
                                                        -------------    -------------
              Total other expense                               4,244            4,126

Income (loss) before income taxes                              (5,980)           2,137

Provision of income taxes                                        --                915
                                                        -------------    -------------
Net (loss) income                                              (5,980)           1,222

Preferred stock dividends                                         229              229
                                                        -------------    -------------

Net (loss) income attributable to common shareholders   $      (6,209)   $         993
                                                        =============    =============

Net (loss) per common share (basic and diluted)         $       (1.98)   $         .32
                                                        =============    =============

Weighted average common shares outstanding                      3,139            3,104
                                                        =============    =============
</TABLE>

The Company estimates the above results for the quarter ended September 30,
1999. The Company is currently preforming internal audits on sales and inventory
and the above results are, therefore, preliminary and subject to change. If
sales and inventory prove to be higher as a result of the sales and inventory
audit, the above results would be favorably impacted. The Company plans a
physical inventory in the second quarter of fiscal 2000.

NET SALES decreased to $36.1 million in the first quarter of fiscal 2000 from
$40.0 million in the same period of fiscal 1999, a decrease of $3.9 million, or
9.8%. The

                                       4

<PAGE>   5

decrease was due in part to the planned system implementation with trade sales
loaded into the fourth quarter of fiscal 1999. Outside resin sales were also
lower.

GROSS PROFIT decreased to $10.9 million for the first quarter of fiscal 2000,
down from $17.4 million in the same period of the prior year, a decrease of $6.5
million. As a percentage of sales, gross margin decreased to 30.2% for the first
quarter of fiscal 2000 from 43.5% in the comparable period of the prior year.
The Company's gross profit in the first quarter of fiscal 2000 was unfavorably
affected by lower sales. The Company's gross profit also continues to be
negatively affected by higher costs of outside manufacturing and storage,
throughput problems and inefficiencies in the plant and warehouse.

SELLING, GENERAL AND ADMINISTRATIVE expenses increased to $12.6 million for the
first quarter of fiscal 2000 from $11.1 million in the same period of fiscal
1999, an increase of $1.5 million or 13.5%. The increase was the result of
several factors including severance costs, higher legal and accounting costs
primarily related to bank negotiations and higher salaries and wages primarily
in the distribution center.

EBITDA for the first quarter of fiscal 2000 is currently estimated at $.9
million. This compares to $9.1 million in the same period of fiscal 1999. This
decrease is primarily due to the factors discussed above which include lower
sales and higher costs related to outside manufacturing and storage, throughput
problems and inefficiencies in the plant and warehouse.


                                       5




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission